Polymorphisms of rs174616 in the FADS1-FADS2 gene cluster is associated with a reduced risk of type 2 diabetes mellitus in northern Han Chinese people

Diabetes Research and Clinical Practice

Volumn 109, Issue 1, 2015, Pages 206-212

  Yao, Min ^a   Li, Jing ^b   Xie, Tian ^a   He, Tianbo ^a   Fang, Lijia ^a   Shi, Yun ^a   Hou, Lianguo ^a   Lian, Kaoqi ^a   Wang, Ruiying ^a   Jiang, Lingling ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b HEBEI GENERAL HOSPITAL   (China)

Author keywords

Arachidonic acid; Desaturase; FADS1 FADS2 gene cluster; PUFA; Type 2 diabetes mellitus

Indexed keywords

ACYL COENZYME A DESATURASE; ACYL COENZYME A DESATURASE 1; ARACHIDONIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; LINOLEOYL COENZYME A DESATURASE; PROTEIN FADS2; THYMINE; UNCLASSIFIED DRUG; DELTA-5 FATTY ACID DESATURASE; FADS2 PROTEIN, HUMAN;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CASE CONTROL STUDY; CODOMINANCE; CONTROLLED STUDY; DOMINANT INHERITANCE; ENZYME ACTIVITY; FEMALE; GENE CLUSTER; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC RISK; HAN CHINESE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK REDUCTION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ALLELE; CHINA; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; MULTIGENE FAMILY; RISK FACTOR;

ADULT; AGED; ALLELES; ALPHA-LINOLENIC ACID; ARACHIDONIC ACID; CASE-CONTROL STUDIES; CHINA; DIABETES MELLITUS, TYPE 2; FATTY ACID DESATURASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MULTIGENE FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84930818508     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2015.03.009     Document Type: Article

References (30)

1. Inzucchi S.E., Bergenstal R.M., Buse J.B., Diamant M., Ferrannini E., Nauck M., et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012, 35:1364-1379.
2. Grenier-Larouche T., Labbé S.M., Noll C., et al. Metabolic inflexibility of white and brown adipose tissues in abnormal fatty acid partitioning of type 2 diabetes. Int J Obesity Suppl 2012, 2:S37-S42. 10.1038/ijosup.2012.21.
3. Rasic-Milutinovic Z., Popovic T., Perunicic-Pekovic G., Arsic A., Borozan S., Glibetic M. Lower serum paraoxonase-1 activity is related to linoleic and docosahexanoic fatty acids in type 2 diabetic patients. Arch Med Res 2012, 43:75-82.
4. Huang T., Sun J., Chen Y., Xie H., Xu D., Huang J., et al. Genetic variants in desaturase gene, erythrocyte fatty acids, and risk for type 2 diabetes in Chinese Hans. Nutrition 2014, 30:897-902.
5. Kroger J., Zietemann V., Enzenbach C., Weikert C., Jansen E.H., Doring F., et al. Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 2011, 93:127-142.
6. Imamura S., Morioka T., Yamazaki Y., Numaguchi R., Urata H., Motoyama K., et al. Plasma polyunsaturated fatty acid profile and delta-5 desaturase activity are altered in patients with type 2 diabetes. Metabolism 2014, 63:1432-1438.
7. Raza Shaikh S., Brown D.A. Models of plasma membrane organization can be applied to mitochondrial membranes to target human health and disease with polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 2013, 88:21-25.
8. Calder P.C. Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim Biophys Acta 2015, 185(4):469-484.
9. Kremmyda L.S., Tvrzicka E., Stankova B., Zak A. Fatty acids as biocompounds: their role in human metabolism, health and disease: a review. Part 2: fatty acid physiological roles and applications in human health and disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2011, 155(3):195-218.
10. Duda M.K. Polyunsaturated fatty acids omega-3 as modulators of intracellular signaling pathways. Postepy Biochem 2012, 58:149-154.
11. Nakamura M.T., Nara T.Y. Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annu Rev Nutr 2004, 24:345-376.
12. Xie L., Innis S.M. Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation. J Nutr 2008, 138:2222-2228.
13. Zhu J., Sun Q., Zong G., Si Y., Liu C., Qi Q., et al. Interaction between a common variant in FADS1 and erythrocyte polyunsaturated fatty acids on lipid profile in Chinese Hans. J Lipid Res 2013, 54:1477-1483.
14. Bokor S., Dumont J., Spinneker A., Gonzalez-Gross M., Nova E., Widhalm K., et al. Single nucleotide polymorphisms in the FADS gene cluster are associated with delta-5 and delta-6 desaturase activities estimated by serum fatty acid ratios. J Lipid Res 2010, 51:2325-2333.
15. Koletzko B., Lattka E., Zeilinger S., Illig T., Steer C. Genetic variants of the fatty acid desaturase gene cluster predict amounts of red blood cell docosahexaenoic and other polyunsaturated fatty acids in pregnant women: findings from the Avon Longitudinal Study of Parents and Children. Am J Clin Nutr 2011, 93:211-219.
16. Tanaka T., Shen J., Abecasis G.R., Kisialiou A., Ordovas J.M., Guralnik J.M., et al. Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet 2009, 5:e1000338.
17. Merino D.M., Johnston H., Clarke S., Roke K., Nielsen D., et al. Polymorphisms in FADS1 and FADS2 alter desaturase activity in young Caucasian and Asian adults. Mol Genet Metab 2011, 103:171-178.
18. Li S.W., Lin K., Ma P., Zhang Z.L., Zhou Y.D., Lu S.Y., et al. FADS gene polymorphisms confer the risk of coronary artery disease in a Chinese Han population through the altered desaturase activities: based on high-resolution melting analysis. PLOS ONE 2013, 8:e55869.
19. Kwak J.H., Paik J.K., Kim O.Y., Jang Y., Lee S.H., Ordovas J.M., Lee J.H. FADS gene polymorphisms in Koreans: association with omega6 polyunsaturated fatty acids in serum phospholipids, lipid peroxides, and coronary artery disease. Atherosclerosis 2011, 214:94-100.
20. Martinelli N., Girelli D., Malerba G., Guarini P., Illig T., Trabetti E., et al. FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. Am J Clin Nutr 2008, 88:941-949.
21. Patel P.S., Sharp S.J., Jansen E., Luben R.N., Khaw K.T., Wareham N.J., Forouhi N.G. Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. Am J Clin Nutr 2010, 92:1214-1222.
22. Hou L., Lian K., Yao M., Shi Y., Lu X., Fang L., et al. Reduction of n-3 PUFAs, specifically DHA and EPA, and enhancement of peroxisomal beta-oxidation in type 2 diabetic rat heart. Cardiovasc Diabetol 2012, 11:126.
23. Mahendran Y., Agren J., Uusitupa M., Cederberg H., Vangipurapu J., Stancakova A., et al. Association of erythrocyte membrane fatty acids with changes in glycemia and risk of type 2 diabetes. Am J Clin Nutr 2014, 99:79-85.
24. Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011, 11:98-107.
25. Sergeant S., Hugenschmidt C.E., Rudock M.E., Ziegler J.T., Ivester P., Ainsworth H.C., et al. Differences in arachidonic acid levels and fatty acid desaturase (FADS) gene variants in African Americans and European Americans with diabetes or the metabolic syndrome. Br J Nutr 2012, 107:547-555.
26. Kroger J., Schulze M.B. Recent insights into the relation of Delta5 desaturase and Delta6 desaturase activity to the development of type 2 diabetes. Curr Opin Lipidol 2012, 23:4-10.
27. Groeger A.L., Cipollina C., Cole M.P., Woodcock S.R., Bonacci G., Rudolph T.K., et al. Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids. Nat Chem Biol 2010, 6:433-441.
28. Oh D.Y., Talukdar S., Bae E.J., Imamura T., Morinaga H., Fan W., et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142:687-698.
29. Zuniga J., Cancino M., Medina F., Varela P., Vargas R., Tapia G., et al. n-3 PUFA supplementation triggers PPAR-alpha activation and PPAR-alpha/NF-kappaB interaction: anti-inflammatory implications in liver ischemia-reperfusion injury. PLoS ONE 2011, 6:e28502.
30. Harslof L.B., Larsen L.H., Ritz C., Hellgren L.I., Michaelsen K.F., Vogel U., Lauritzen L. FADS genotype and diet are important determinants of DHA status: a cross-sectional study in Danish infants. Am J Clin Nutr 2013, 97:1403-1410.